← brief for 2026-10-13 · Slowing decline

Glucagon-like Peptide-1-based and Emerging Cardiometabolic Therapies in Heart Failure with Preserved Ejection Fraction: Linking Molecular Mechanisms to Clinical Outcomes.

Paper No results yet Peer reviewed

Key takeaways

This review discusses new drugs for heart failure. It links these drugs to kidney and metabolic health. It is a summary of existing research, not a new trial with results.

Who did this work

Merolla A · Rovere-Querini P

Source

Paper · PubMed, the drug frontier · 2026 Sep 30
https://pubmed.ncbi.nlm.nih.gov/42865775/